Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBARK.L Regulatory News (BARK)

  • There is currently no data for BARK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Acquisition

7 Jan 2020 07:00

RNS Number : 9147Y
Barkby Group PLC (The)
07 January 2020
 

7 January 2020

The Barkby Group Plc

("the Company")

Completion of Acquisition 

Admission of the New Ordinary Shares to trading on AIM and Directors Shareholding

The Barkby Group PLC, the consumer-focused hospitality group, confirms that the Company's Existing Ordinary Shares trading on NEX Exchange has today been cancelled. Application has been made to the London Stock Exchange for the Enlarged Share Capital to be admitted to trading on AIM ("Admission") and it is expected that Admission will occur and dealings will commence by 8.00 a.m. today.

On Admission, the Company will complete the acquisitions of Tarncourt Ambit Properties Limited, Tarncourt Ambit Limited and Workshop Trading Holdings Limited (together the "Dickson Controlled Entities") and the Placing and Subscription ("Completion"). 

This follows the announcements on 19 December 2019 in relation to the Reverse Takeover, Placing and Subscription and on 6 January 2020 in relation to the passing of the Resolutions at the General Meeting.

Following Admission and Completion, the total number of Shares in issue will be 135,235,066. There are no Shares held in treasury. Accordingly, the total number of voting rights in the Company on Admission will be 135,235,066. This figure may be used by Shareholders as the denominator for the calculations to determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Giles Clarke (Non-Executive Chairman) and Rupert Fraser (Chief Executive Officer) subscribed at the Issue Price for 250,000 and 666,667 New Ordinary Shares in the Placing and Subscription respectively. The tables below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail on the transaction.

Charles Dickson, Executive Chairman of The Barkby Group Plc, commented:

"This is a transformational acquisition for all of us and I am very excited to be leading the business as Executive Chairman. The Group now consists of a diverse portfolio of high growth, high quality businesses and several very exciting early stage businesses with the potential to significantly disrupt the markets within which they operate.

"Our enhanced scale and capital will provide a strong platform for growth and deliver value for our shareholders. I would like to thank all our stakeholders for their continued support as the business moves into a new chapter."

Defined terms used in this announcement will have the meaning (unless the context otherwise requires) as set out in the Admission Document which is available on the Company's website www.barkbygroup.com. This announcement should be read in conjunction with the Admission Document published by the Company on 19 December 2019.

Enquiries: 

finnCap Ltd (Corporate Adviser and Broker)

Carl Holmes/Simon Hicks (corporate finance)

Tim Redfern/Richard Chambers (ECM)

 

+44 (0) 20 7220 0500

Camarco (Financial PR)

Jennifer Renwick/Jane Glover

+44 (0) 20 3757 4994

 

Notes to editors

The Barkby Group PLC is a diversified group of high growth, high quality businesses run by an entrepreneurial and experienced management team. The existing wholly owned businesses within Barkby include; Commercial Property Development, Barkby Hospitality (comprising Barkby Pubs and Workshop Coffee) and Centurian Automotive. In addition to these businesses, Barkby has the right to participate in the upcoming fundraisings for two disruptive high growth private companies: Transcend Packaging, a sustainable and innovative paper packaging manufacturer aiming to eliminate single use plastic, and VivoPlex, a digital health company aiming to transform fertility treatment with precision medicine. Barkby's strategy is to accelerate and maximise opportunities within its existing businesses as well as continue to source and invest in cash generative, growth businesses with the ability to disrupt.

Directors Shareholding

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Rupert Fraser

2.

Reason for the notification

a)

Position/status:

Chief Executive Officer

 

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

The Barkby Group Plc

b)

LEI:

213800X57YXZVILB9E84

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 30 pence each

 

GB00B13GSS58

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

30 pence

666,667

 

 

d)

Aggregated information:

Aggregated volume:

Price:

As above

e)

Date of the transaction:

6 January 2020

f)

Place of the transaction:

NEX Exchange

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Giles Clarke

2.

Reason for the notification

a)

Position/status:

Non-Executive Chairman

 

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

The Barkby Group Plc

b)

LEI:

213800X57YXZVILB9E84

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 30 pence each

 

GB00B13GSS58

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

30 pence

250,000

 

 

d)

Aggregated information:

Aggregated volume:

Price:

As above

e)

Date of the transaction:

6 January 2020

f)

Place of the transaction:

NEX Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NEXUNUARRAUARUR
12
Date   Source Headline
27th Oct 20219:05 amRNSSecond Price Monitoring Extn
27th Oct 20219:00 amRNSPrice Monitoring Extension
27th Oct 20217:00 amRNSTrading Statement and Property Acquisition
10th Aug 20217:00 amRNSTrading Statement
16th Jun 20217:00 amRNSNew lease for The Ebrington Arms
19th May 202111:05 amRNSSecond Price Monitoring Extn
19th May 202111:00 amRNSPrice Monitoring Extension
7th May 20211:48 pmRNSResult of AGM and change of name
30th Apr 20217:00 amRNSInterim Results
15th Apr 20217:00 amRNSCambridge Sleep Sciences signs new partners
9th Apr 20217:00 amRNSPosting of Annual Report & Notice of AGM
8th Apr 20217:00 amRNSVerso Biosense signs collaboration agreement
31st Mar 20216:29 pmRNSFinal Results
25th Mar 20217:00 amRNSVerso Biosense signs agreement with hospital
11th Mar 20217:00 amRNSCambridge Sleep Sciences partnership announcement
3rd Mar 20217:00 amRNSTrading Update
25th Jan 20217:00 amRNSExchange of Contracts at Malden, Essex
24th Dec 20207:00 amRNSExtension of Warrants
21st Dec 20207:00 amRNSExercise of Warrants and Total Voting Rights
6th Nov 20207:03 amRNSExtension of Reporting Deadline
30th Oct 20207:00 amRNSWorkshop Coffee becomes UK Distributor for MiiR
23rd Oct 20207:00 amRNSCambridge Sleep Sciences Ltd launches 'SleepHub™'
30th Sep 20207:00 amRNSCompany Update and Issue of Equity
17th Sep 20207:00 amRNSNew lease for The Harcourt Arms
10th Aug 20207:00 amRNSPractical Completion of Hastings
3rd Aug 20207:00 amRNSInvestment in VivoPlex Group
22nd Jul 20207:00 amRNSUpdate and CBILS loan
21st Apr 20207:00 amRNSAgreement with Cambridge Sound Technologies
20th Apr 20207:32 amRNSVivoPlex prepares for clinical feasibility study
24th Mar 20202:57 pmRNSDirector/PDMR Shareholding
24th Mar 20207:00 amRNSConfirmation of Director Appointment
23rd Mar 20207:00 amRNSInterim Results
3rd Mar 20207:00 amRNSProposed acquisition
6th Feb 20207:00 amRNSAppointment of Senior Manager
3rd Feb 20207:00 amRNSAppointment of Chief Financial Officer
17th Jan 20207:00 amRNSExchange of Contracts at Huntingdon
7th Jan 20207:00 amRNSCompletion of Acquisition
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.